Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer [Corrigendum]

Authors Li D, Ma L, Bao J, Cao L, Min W

Received 18 April 2023

Accepted for publication 18 April 2023

Published 21 April 2023 Volume 2023:16 Pages 1071—1072

DOI https://doi.org/10.2147/CCID.S417684



Li D, Ma L, Bao J, Cao L, Min W. Clin Cosmet Investig Dermatol. 2023;16:1–8.

The authors have advised that there is an error to Dr Dan Li’s affiliation.

On page 1, the correct affiliation for Drs Dan Li, 1 Liwen Ma,1 and Jun Bao,1 should read from 1Department of Dermatology, the Affiliated Hospital of Nanjing University Medical School, Nanjing, People’s Republic of China to 1Department of Dermatology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People’s Republic of China.

The updated author list and affiliations should read as follows:

Dan Li,1 Liwen Ma,1 Jun Bao,1 Lei Cao,2 Wei Min3

1Department of Dermatology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People’s Republic of China; 2Clinical Immunology Laboratory, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, People’s Republic of China; 3Department of Dermatology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, People’s Republic of China

The authors apologize for this oversight.


Read the original article


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.